Related Experiment Video

Updated: Jun 18, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Androgen receptor functioned as a suppressor in the prostate cancer cell line PC3 in vitro and in vivo

Sheng-qiang Yu1, Bang-min Han, Yi Shao

  • 1Department of Urology, First People's Hospital of Shanghai Jiao Tong University, Shanghai, China.

Chinese Medical Journal
|December 3, 2009
PubMed
Abstract

Insights

Restoring the androgen receptor (AR) in prostate cancer cells unexpectedly reduced proliferation and metastasis. This suggests AR may act as a tumor suppressor in certain prostate cancer models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Prostate cancer incidence is rising globally, particularly in China.
  • Androgen deprivation therapy is standard for advanced prostate cancer.
  • The function of the androgen receptor (AR) in hormone-refractory prostate cancer remains incompletely understood.

Purpose of the Study:

  • To investigate the role of AR in an androgen-independent prostate cancer cell line.
  • To determine AR's impact on cancer cell proliferation and metastasis.
  • To evaluate AR's effect in both in vitro and in vivo models.

Main Methods:

  • Utilized PC3-AR9, a PC3 cell line engineered to express human AR.
  • Assessed proliferation and invasion using MTT, soft agar, chamber invasion, and wound healing assays.
  • Evaluated tumor growth and metastasis in an orthotopic xenograft mouse model.

Main Results:

  • Restoring AR expression in PC3 cells led to reduced proliferation and invasion/metastasis.
  • In vivo studies showed PC3-AR9 xenografts had smaller primary and metastatic tumors.
  • PC3-AR9 tumors exhibited decreased proliferation rates and increased apoptosis compared to controls.

Conclusions:

  • Androgen receptor (AR) may function as a tumor suppressor in the context of PC3 prostate cancer cells.
  • These findings challenge conventional understanding of AR's role in hormone-refractory prostate cancer.
  • Further research is warranted to elucidate the precise mechanisms of AR's tumor-suppressive activity.

More Related Videos

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...